{
    "title": "103_s1249",
    "content": "This Act is titled the \"Tuberculosis Prevention and Control Amendments of 1993\" and includes findings related to tuberculosis prevention and control. Between 10,000,000 and 15,000,000 people in the United States have been infected with tuberculosis, with nearly 26,000 new cases reported each year. Drug-resistant tuberculosis strains can cost over $150,000 to treat, and between 40 and 60 percent of patients receiving such treatment die. In 1992, all 50 states reported tuberculosis cases to the Centers for Disease Control and Prevention. In 1992, 27 percent of tuberculosis cases occurred in foreign born persons, and one third of the world's population harbors tuberculosis. Tuberculosis remains the number one killer among infectious diseases worldwide, with 8,000,000 new cases and 2,900,000 deaths annually. Programs of Centers for Disease Control and Prevention. The amendment to the Public Health Service Act allocates funding for tuberculosis prevention, control, and elimination services for fiscal years 1994 through 1997. States applying for grants must submit a plan demonstrating how the funds will be used to provide tuberculosis services. The amendment to the Public Health Service Act requires states to submit plans for providing tuberculosis services to high-risk populations or areas with high infection rates. Plans must show collaboration with other entities and use of grant funds for effective interventions. The amendment to the Public Health Service Act authorizes funding for research and training on tuberculosis surveillance, prevention, and treatment. $26,000,000 is authorized for fiscal year 1994, with additional funding for the following years. The Public Health Service Act authorizes funding for tuberculosis research and training. $26,000,000 is authorized for fiscal year 1994, with additional funding for subsequent years. Additionally, a technical amendment is made to Section 317(j)(2) of the Act. The Public Health Service Act authorizes funding for tuberculosis research and training, with $26,000,000 authorized for fiscal year 1994. A technical amendment is made to Section 317(j)(2) of the Act to support research and research training regarding tuberculosis through the National Institute of Allergy and Infectious Diseases. The Public Health Service Act authorizes $46,000,000 for tuberculosis research through the National Institute on Allergy and Infectious Diseases in fiscal year 1994. The Public Health Service Act authorized $46,000,000 for tuberculosis research in fiscal year 1994, with additional funding for the following fiscal years up to 1997. The authorization of appropriations does not affect the availability of other funding sources for the same purpose. The Food, Drug and Cosmetic Act is amended to include a new section for tuberculosis drug and device research. The Commissioner of Food and Drugs will implement a program to assist in developing tuberculosis protocols, review medical devices for tuberculosis diagnosis, and conduct research on drugs and devices for tuberculosis prevention. $5,000,000 is authorized for this program annually."
}